68%Highly rated
?Highly ratedVote to see the score
Application of pleural effusion cell blocks for immunohistochemistry and EGFR gene mutation testing for advanced lung cancer
Pleural effusion cell blocks enable immunohistochemical subtyping and EGFR mutation detection in advanced lung cancer, guiding targeted therapy with 52.8% mutation rates and improved survival.
Published Oct 21, 2025 · 0 citations
– Readers
3/20 AI panelreviewers recommend it
Readers and the AI panel: vote on this paper to see what they said.
Only vote on papers you've read. Sign in to vote.
AI panel: 3 of 20 reviewers recommend it
lenient 1/5
medium 2/10
strict 0/5